| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mandible | 84 | 2022 | 740 | 8.300 |
Why?
|
| Osteogenesis, Distraction | 39 | 2018 | 219 | 6.890 |
Why?
|
| Temporomandibular Joint Disorders | 28 | 2022 | 215 | 6.330 |
Why?
|
| Mandibular Condyle | 29 | 2023 | 115 | 5.050 |
Why?
|
| Orthognathic Surgical Procedures | 19 | 2021 | 115 | 4.700 |
Why?
|
| Temporomandibular Joint | 29 | 2021 | 196 | 4.020 |
Why?
|
| Cephalometry | 39 | 2021 | 382 | 3.970 |
Why?
|
| Surgery, Oral | 13 | 2022 | 146 | 3.430 |
Why?
|
| Jaw Neoplasms | 15 | 2019 | 70 | 3.360 |
Why?
|
| Maxilla | 26 | 2021 | 471 | 3.220 |
Why?
|
| Facial Asymmetry | 22 | 2014 | 171 | 2.910 |
Why?
|
| Pharynx | 9 | 2012 | 413 | 2.800 |
Why?
|
| Mandibular Advancement | 17 | 2016 | 64 | 2.730 |
Why?
|
| Mandibular Fractures | 16 | 2019 | 73 | 2.600 |
Why?
|
| Giant Cell Tumor of Bone | 10 | 2019 | 116 | 2.320 |
Why?
|
| Oral Surgical Procedures | 15 | 2022 | 168 | 2.320 |
Why?
|
| Synovitis | 6 | 2017 | 209 | 2.100 |
Why?
|
| Osteotomy | 39 | 2022 | 822 | 1.900 |
Why?
|
| Anesthesia, Dental | 5 | 2022 | 67 | 1.760 |
Why?
|
| Mandibular Neoplasms | 13 | 2019 | 129 | 1.700 |
Why?
|
| Bone Transplantation | 35 | 2018 | 907 | 1.650 |
Why?
|
| Granuloma, Giant Cell | 9 | 2021 | 33 | 1.600 |
Why?
|
| Spinal Injuries | 3 | 2019 | 301 | 1.570 |
Why?
|
| Mandibular Nerve | 14 | 2022 | 58 | 1.560 |
Why?
|
| Sleep Apnea, Obstructive | 14 | 2016 | 1813 | 1.530 |
Why?
|
| Maxillary Neoplasms | 5 | 2016 | 45 | 1.470 |
Why?
|
| Facial Bones | 14 | 2019 | 201 | 1.390 |
Why?
|
| Mandibular Diseases | 15 | 2016 | 119 | 1.380 |
Why?
|
| Swine, Miniature | 28 | 2015 | 961 | 1.250 |
Why?
|
| Imaging, Three-Dimensional | 17 | 2018 | 4042 | 1.250 |
Why?
|
| Neck Injuries | 2 | 2019 | 152 | 1.230 |
Why?
|
| Hospitals, General | 6 | 2020 | 749 | 1.190 |
Why?
|
| Malocclusion | 8 | 2021 | 130 | 1.160 |
Why?
|
| Ameloblastoma | 4 | 2017 | 41 | 1.140 |
Why?
|
| Radiography, Panoramic | 10 | 2018 | 115 | 1.130 |
Why?
|
| Giant Cell Tumors | 6 | 2012 | 99 | 1.100 |
Why?
|
| Ankylosis | 8 | 2013 | 39 | 1.030 |
Why?
|
| Anesthesiology | 4 | 2022 | 1060 | 1.020 |
Why?
|
| Patient Care Planning | 10 | 2020 | 921 | 1.020 |
Why?
|
| Micrognathism | 5 | 2012 | 57 | 1.010 |
Why?
|
| Bone Regeneration | 10 | 2015 | 427 | 1.010 |
Why?
|
| Malocclusion, Angle Class II | 4 | 2018 | 33 | 0.970 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 2 | 2024 | 36 | 0.970 |
Why?
|
| Orthognathic Surgery | 4 | 2020 | 32 | 0.970 |
Why?
|
| Prognathism | 5 | 2014 | 26 | 0.960 |
Why?
|
| Osteotomy, Le Fort | 12 | 2021 | 89 | 0.940 |
Why?
|
| Endoscopy | 11 | 2013 | 1787 | 0.940 |
Why?
|
| Orthodontics | 2 | 2021 | 75 | 0.930 |
Why?
|
| Maxillofacial Development | 11 | 2009 | 88 | 0.910 |
Why?
|
| Osteogenesis | 24 | 2015 | 1299 | 0.900 |
Why?
|
| Schools, Dental | 4 | 2015 | 122 | 0.880 |
Why?
|
| Dental Occlusion | 3 | 2019 | 54 | 0.880 |
Why?
|
| Fibrous Dysplasia of Bone | 4 | 2024 | 54 | 0.850 |
Why?
|
| Joint Prosthesis | 2 | 2021 | 258 | 0.820 |
Why?
|
| Surgery, Computer-Assisted | 6 | 2016 | 1018 | 0.760 |
Why?
|
| Lingual Nerve | 11 | 2013 | 33 | 0.750 |
Why?
|
| Retrospective Studies | 94 | 2022 | 77460 | 0.740 |
Why?
|
| Exploratory Behavior | 1 | 2021 | 270 | 0.730 |
Why?
|
| Publication Bias | 1 | 2021 | 162 | 0.730 |
Why?
|
| Swine | 36 | 2015 | 5918 | 0.720 |
Why?
|
| Adolescent | 109 | 2021 | 85779 | 0.720 |
Why?
|
| Jaw Diseases | 11 | 2009 | 90 | 0.710 |
Why?
|
| Tomography, X-Ray Computed | 30 | 2018 | 20130 | 0.690 |
Why?
|
| Humans | 273 | 2024 | 744366 | 0.690 |
Why?
|
| Temporomandibular Joint Dysfunction Syndrome | 7 | 2013 | 23 | 0.670 |
Why?
|
| Morals | 1 | 2021 | 285 | 0.660 |
Why?
|
| Cleft Lip | 11 | 2007 | 478 | 0.640 |
Why?
|
| Child | 106 | 2022 | 77709 | 0.640 |
Why?
|
| Female | 197 | 2022 | 380193 | 0.620 |
Why?
|
| Interferon-alpha | 5 | 2007 | 895 | 0.610 |
Why?
|
| Maxillary Artery | 2 | 2013 | 18 | 0.610 |
Why?
|
| Terminology as Topic | 4 | 2016 | 1547 | 0.600 |
Why?
|
| Fibroma, Ossifying | 3 | 2012 | 19 | 0.600 |
Why?
|
| Cartilage | 13 | 2015 | 818 | 0.590 |
Why?
|
| Skull Fractures | 3 | 2006 | 195 | 0.580 |
Why?
|
| Trigeminal Neuralgia | 2 | 2013 | 113 | 0.570 |
Why?
|
| Bone Density Conservation Agents | 3 | 2021 | 772 | 0.570 |
Why?
|
| Jaw | 5 | 2021 | 96 | 0.560 |
Why?
|
| Respiratory System | 2 | 2010 | 557 | 0.560 |
Why?
|
| Male | 165 | 2022 | 350115 | 0.550 |
Why?
|
| Dental Service, Hospital | 1 | 2015 | 5 | 0.550 |
Why?
|
| Mouth Diseases | 5 | 2013 | 241 | 0.540 |
Why?
|
| Proliferating Cell Nuclear Antigen | 5 | 2014 | 285 | 0.540 |
Why?
|
| Osteomyelitis | 4 | 2016 | 402 | 0.540 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2016 | 2038 | 0.530 |
Why?
|
| General Practice, Dental | 1 | 2015 | 33 | 0.530 |
Why?
|
| Incidental Findings | 1 | 2020 | 689 | 0.520 |
Why?
|
| Neck Muscles | 3 | 2015 | 104 | 0.520 |
Why?
|
| Bone Plates | 5 | 2012 | 468 | 0.520 |
Why?
|
| Foundations | 1 | 2015 | 94 | 0.520 |
Why?
|
| Bone Resorption | 8 | 2008 | 723 | 0.500 |
Why?
|
| Goldenhar Syndrome | 1 | 2014 | 37 | 0.490 |
Why?
|
| Child, Preschool | 57 | 2019 | 41005 | 0.490 |
Why?
|
| Hyoid Bone | 5 | 2012 | 38 | 0.480 |
Why?
|
| Sensation | 8 | 2013 | 336 | 0.480 |
Why?
|
| Osteoblasts | 14 | 2012 | 1166 | 0.470 |
Why?
|
| Bone Neoplasms | 5 | 2019 | 2530 | 0.470 |
Why?
|
| Maxillary Diseases | 4 | 2006 | 51 | 0.470 |
Why?
|
| Craniofacial Abnormalities | 6 | 2016 | 315 | 0.460 |
Why?
|
| Sensation Disorders | 9 | 2007 | 156 | 0.460 |
Why?
|
| Surgery, Plastic | 13 | 2009 | 624 | 0.450 |
Why?
|
| Debridement | 2 | 2016 | 492 | 0.450 |
Why?
|
| Mouth Floor | 1 | 2013 | 34 | 0.450 |
Why?
|
| Airway Obstruction | 5 | 2012 | 664 | 0.450 |
Why?
|
| Adult | 116 | 2022 | 214052 | 0.450 |
Why?
|
| Arthralgia | 3 | 2016 | 456 | 0.440 |
Why?
|
| Education, Dental, Graduate | 3 | 2015 | 48 | 0.430 |
Why?
|
| Chin | 5 | 2011 | 38 | 0.420 |
Why?
|
| Maxillofacial Injuries | 6 | 2011 | 33 | 0.420 |
Why?
|
| Dermoid Cyst | 1 | 2013 | 93 | 0.420 |
Why?
|
| Head | 2 | 2017 | 880 | 0.420 |
Why?
|
| Odontogenic Cysts | 2 | 2003 | 41 | 0.410 |
Why?
|
| Bone Morphogenetic Protein 4 | 2 | 2012 | 162 | 0.410 |
Why?
|
| Learning | 1 | 2021 | 1711 | 0.410 |
Why?
|
| Internship and Residency | 6 | 2019 | 5791 | 0.410 |
Why?
|
| Embalming | 1 | 2011 | 13 | 0.410 |
Why?
|
| Mummies | 1 | 2011 | 11 | 0.410 |
Why?
|
| Ribs | 6 | 2008 | 252 | 0.400 |
Why?
|
| Odontogenic Tumors | 3 | 2019 | 45 | 0.400 |
Why?
|
| Fibroma | 2 | 2013 | 212 | 0.400 |
Why?
|
| Education, Medical | 2 | 2022 | 1722 | 0.390 |
Why?
|
| Research Support as Topic | 1 | 2015 | 705 | 0.380 |
Why?
|
| Nose | 6 | 2011 | 509 | 0.380 |
Why?
|
| Pharyngeal Muscles | 1 | 2010 | 77 | 0.370 |
Why?
|
| Fetus | 9 | 1998 | 1880 | 0.370 |
Why?
|
| Anesthetics, Inhalation | 2 | 2011 | 570 | 0.370 |
Why?
|
| Malocclusion, Angle Class III | 4 | 2021 | 38 | 0.360 |
Why?
|
| Massachusetts | 9 | 2020 | 8662 | 0.360 |
Why?
|
| Embolization, Therapeutic | 3 | 2014 | 1392 | 0.350 |
Why?
|
| Neoplasm Invasiveness | 4 | 2012 | 3616 | 0.350 |
Why?
|
| Radiography | 16 | 2021 | 7023 | 0.350 |
Why?
|
| Orthodontics, Corrective | 6 | 2020 | 75 | 0.340 |
Why?
|
| Fractures, Bone | 4 | 2019 | 1947 | 0.340 |
Why?
|
| Bony Callus | 3 | 2003 | 36 | 0.340 |
Why?
|
| Ear, External | 4 | 2007 | 161 | 0.330 |
Why?
|
| Palatal Neoplasms | 2 | 2011 | 35 | 0.330 |
Why?
|
| Patient Care Management | 1 | 2012 | 306 | 0.330 |
Why?
|
| Tooth Extraction | 9 | 2007 | 222 | 0.330 |
Why?
|
| Physical Examination | 2 | 2013 | 1237 | 0.320 |
Why?
|
| Jaw Fixation Techniques | 3 | 2008 | 8 | 0.320 |
Why?
|
| Arthroplasty | 2 | 2009 | 305 | 0.310 |
Why?
|
| Faculty, Dental | 3 | 2015 | 60 | 0.310 |
Why?
|
| Angiography | 1 | 2013 | 1639 | 0.310 |
Why?
|
| Cherubism | 2 | 2021 | 16 | 0.310 |
Why?
|
| User-Computer Interface | 7 | 2016 | 1431 | 0.310 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2011 | 555 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2021 | 35425 | 0.310 |
Why?
|
| Follow-Up Studies | 36 | 2021 | 39052 | 0.300 |
Why?
|
| Temporal Bone | 4 | 2017 | 661 | 0.300 |
Why?
|
| Young Adult | 22 | 2020 | 56429 | 0.290 |
Why?
|
| Dental Stress Analysis | 2 | 2003 | 65 | 0.290 |
Why?
|
| Mentors | 2 | 2022 | 631 | 0.290 |
Why?
|
| Clinical Competence | 3 | 2017 | 4687 | 0.290 |
Why?
|
| Treatment Outcome | 40 | 2019 | 63107 | 0.290 |
Why?
|
| Gadolinium DTPA | 3 | 2016 | 836 | 0.290 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 1078 | 0.290 |
Why?
|
| Prosthesis Implantation | 1 | 2011 | 642 | 0.280 |
Why?
|
| Internal Fixators | 5 | 2012 | 188 | 0.280 |
Why?
|
| Palate, Hard | 3 | 2012 | 57 | 0.280 |
Why?
|
| Fracture Fixation | 6 | 2011 | 354 | 0.280 |
Why?
|
| Osteosarcoma | 6 | 2012 | 881 | 0.280 |
Why?
|
| Tissue Engineering | 8 | 2011 | 1880 | 0.280 |
Why?
|
| Dental Arch | 3 | 2011 | 38 | 0.270 |
Why?
|
| Triamcinolone Acetonide | 2 | 2016 | 101 | 0.270 |
Why?
|
| Wound Infection | 2 | 2000 | 242 | 0.270 |
Why?
|
| Software | 4 | 2017 | 4441 | 0.270 |
Why?
|
| Palate, Soft | 3 | 2010 | 96 | 0.270 |
Why?
|
| Nicotinic Agonists | 1 | 2007 | 271 | 0.260 |
Why?
|
| History, 19th Century | 4 | 2013 | 720 | 0.260 |
Why?
|
| Boston | 8 | 2018 | 9312 | 0.260 |
Why?
|
| Face | 10 | 2006 | 994 | 0.260 |
Why?
|
| Bone Matrix | 5 | 2007 | 118 | 0.260 |
Why?
|
| Feasibility Studies | 9 | 2017 | 5077 | 0.250 |
Why?
|
| Models, Animal | 10 | 2015 | 2173 | 0.250 |
Why?
|
| Infant | 28 | 2019 | 35134 | 0.250 |
Why?
|
| Periosteum | 3 | 2012 | 138 | 0.250 |
Why?
|
| Contrast Media | 7 | 2018 | 5300 | 0.250 |
Why?
|
| Alveolar Process | 7 | 2007 | 293 | 0.250 |
Why?
|
| Cervical Vertebrae | 3 | 2019 | 976 | 0.240 |
Why?
|
| Tongue | 4 | 2011 | 406 | 0.240 |
Why?
|
| Cohort Studies | 21 | 2017 | 40559 | 0.240 |
Why?
|
| Surgical Flaps | 7 | 2011 | 1640 | 0.240 |
Why?
|
| Esthetics, Dental | 2 | 2018 | 251 | 0.240 |
Why?
|
| Cranial Nerve Injuries | 2 | 2003 | 25 | 0.240 |
Why?
|
| Larynx | 1 | 2009 | 494 | 0.240 |
Why?
|
| Computer-Aided Design | 2 | 2018 | 298 | 0.240 |
Why?
|
| Range of Motion, Articular | 5 | 2013 | 1578 | 0.230 |
Why?
|
| Cognition | 1 | 2021 | 6770 | 0.230 |
Why?
|
| Zygomatic Fractures | 5 | 1996 | 37 | 0.230 |
Why?
|
| Time Factors | 30 | 2017 | 40075 | 0.220 |
Why?
|
| Fetal Diseases | 4 | 1993 | 903 | 0.220 |
Why?
|
| Statistics, Nonparametric | 6 | 2012 | 2887 | 0.220 |
Why?
|
| Coloring Agents | 4 | 2012 | 566 | 0.220 |
Why?
|
| Arteriovenous Malformations | 5 | 2014 | 396 | 0.220 |
Why?
|
| Cerebrovascular Trauma | 1 | 2022 | 23 | 0.220 |
Why?
|
| Middle Aged | 58 | 2022 | 213390 | 0.220 |
Why?
|
| Technetium Tc 99m Medronate | 6 | 2009 | 136 | 0.220 |
Why?
|
| Nicotine | 1 | 2007 | 681 | 0.220 |
Why?
|
| Tooth | 4 | 2009 | 207 | 0.220 |
Why?
|
| Sex Factors | 8 | 2019 | 10400 | 0.210 |
Why?
|
| Cleft Palate | 6 | 2007 | 560 | 0.210 |
Why?
|
| Animals | 59 | 2015 | 168768 | 0.210 |
Why?
|
| Temporal Muscle | 4 | 2009 | 37 | 0.210 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2019 | 221 | 0.200 |
Why?
|
| Femoral Vein | 1 | 2002 | 159 | 0.200 |
Why?
|
| Fracture Fixation, Internal | 6 | 2004 | 917 | 0.200 |
Why?
|
| Nerve Growth Factor | 1 | 2002 | 149 | 0.200 |
Why?
|
| Rotation | 4 | 2019 | 523 | 0.200 |
Why?
|
| Clinical Protocols | 6 | 2009 | 1461 | 0.190 |
Why?
|
| Peer Review, Research | 2 | 2015 | 329 | 0.190 |
Why?
|
| Age Factors | 13 | 2014 | 18373 | 0.190 |
Why?
|
| Radicular Cyst | 1 | 2000 | 13 | 0.190 |
Why?
|
| Dentigerous Cyst | 1 | 2000 | 17 | 0.190 |
Why?
|
| Random Allocation | 4 | 2012 | 2428 | 0.190 |
Why?
|
| Diagnosis, Differential | 13 | 2013 | 12961 | 0.190 |
Why?
|
| Recurrence | 10 | 2021 | 8340 | 0.190 |
Why?
|
| Mandibulofacial Dysostosis | 2 | 2005 | 34 | 0.190 |
Why?
|
| Gadolinium | 4 | 2018 | 952 | 0.190 |
Why?
|
| Diphosphonates | 6 | 2021 | 623 | 0.180 |
Why?
|
| Hospitals, Teaching | 1 | 2005 | 1180 | 0.180 |
Why?
|
| Prosthesis Design | 3 | 2018 | 2110 | 0.180 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2016 | 450 | 0.180 |
Why?
|
| History, 20th Century | 4 | 2019 | 2740 | 0.180 |
Why?
|
| Epiglottis | 2 | 2010 | 79 | 0.180 |
Why?
|
| Private Practice | 2 | 2015 | 154 | 0.180 |
Why?
|
| Taste Disorders | 1 | 2000 | 41 | 0.180 |
Why?
|
| Recovery of Function | 4 | 2013 | 2926 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 5 | 2016 | 7182 | 0.180 |
Why?
|
| Taste | 2 | 2003 | 176 | 0.180 |
Why?
|
| Esthetics | 2 | 2019 | 306 | 0.180 |
Why?
|
| History of Dentistry | 1 | 2019 | 6 | 0.170 |
Why?
|
| Fracture Healing | 1 | 2002 | 427 | 0.170 |
Why?
|
| Biomedical Technology | 1 | 2002 | 220 | 0.170 |
Why?
|
| Rhizotomy | 1 | 1999 | 30 | 0.170 |
Why?
|
| Wound Healing | 12 | 2010 | 2785 | 0.170 |
Why?
|
| Maxillofacial Prosthesis | 1 | 2018 | 2 | 0.170 |
Why?
|
| Overbite | 1 | 2018 | 12 | 0.170 |
Why?
|
| Bone Density | 8 | 2015 | 3468 | 0.170 |
Why?
|
| Publishing | 3 | 2018 | 833 | 0.170 |
Why?
|
| Dental Care for Chronically Ill | 2 | 1999 | 32 | 0.170 |
Why?
|
| Antigens, CD34 | 3 | 2012 | 659 | 0.160 |
Why?
|
| Stromal Cells | 2 | 2016 | 1355 | 0.160 |
Why?
|
| Biopsy, Needle | 3 | 2005 | 1641 | 0.160 |
Why?
|
| Dentition, Mixed | 1 | 2018 | 10 | 0.160 |
Why?
|
| Neuralgia | 2 | 2024 | 570 | 0.160 |
Why?
|
| Facial Nerve | 2 | 2013 | 271 | 0.160 |
Why?
|
| Hypercalcemia | 1 | 2021 | 409 | 0.160 |
Why?
|
| Motivation | 2 | 2021 | 1971 | 0.160 |
Why?
|
| Skull Neoplasms | 1 | 2019 | 173 | 0.160 |
Why?
|
| Nasal Bone | 5 | 2014 | 58 | 0.160 |
Why?
|
| Submandibular Gland Diseases | 2 | 2008 | 21 | 0.160 |
Why?
|
| Cranial Nerve Diseases | 1 | 1998 | 112 | 0.160 |
Why?
|
| Salivary Ducts | 2 | 2008 | 24 | 0.160 |
Why?
|
| Craniotomy | 1 | 2002 | 729 | 0.150 |
Why?
|
| Tooth Germ | 2 | 2009 | 20 | 0.150 |
Why?
|
| Connective Tissue | 5 | 2015 | 420 | 0.150 |
Why?
|
| RANK Ligand | 1 | 2019 | 326 | 0.150 |
Why?
|
| Odontogenesis | 2 | 2009 | 66 | 0.150 |
Why?
|
| Hematoxylin | 2 | 2010 | 64 | 0.150 |
Why?
|
| Eosine Yellowish-(YS) | 2 | 2010 | 72 | 0.150 |
Why?
|
| Abnormalities, Multiple | 5 | 2015 | 1416 | 0.150 |
Why?
|
| Craniosynostoses | 4 | 2002 | 401 | 0.150 |
Why?
|
| Monitoring, Immunologic | 1 | 2017 | 100 | 0.150 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 1997 | 73 | 0.150 |
Why?
|
| Polytetrafluoroethylene | 1 | 1998 | 233 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 9 | 2019 | 9240 | 0.150 |
Why?
|
| Injury Severity Score | 2 | 2018 | 1014 | 0.150 |
Why?
|
| Oral Hemorrhage | 3 | 1994 | 27 | 0.150 |
Why?
|
| Mesenchymal Stem Cells | 5 | 2013 | 1632 | 0.150 |
Why?
|
| Rosaniline Dyes | 1 | 2016 | 51 | 0.150 |
Why?
|
| Immunohistochemistry | 8 | 2012 | 11366 | 0.140 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 14723 | 0.140 |
Why?
|
| Sleep Stages | 2 | 2011 | 686 | 0.140 |
Why?
|
| Prospective Studies | 15 | 2024 | 53290 | 0.140 |
Why?
|
| Absorbable Implants | 2 | 2011 | 342 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 1790 | 0.140 |
Why?
|
| Open Bite | 1 | 2016 | 19 | 0.140 |
Why?
|
| Occlusal Splints | 1 | 2016 | 20 | 0.140 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2016 | 50 | 0.140 |
Why?
|
| Pain Measurement | 2 | 2016 | 3420 | 0.140 |
Why?
|
| Nerve Regeneration | 2 | 2002 | 788 | 0.140 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 19905 | 0.140 |
Why?
|
| Skin Transplantation | 2 | 2012 | 1074 | 0.140 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2022 | 795 | 0.140 |
Why?
|
| Masseter Muscle | 3 | 2004 | 36 | 0.140 |
Why?
|
| Dental Staff, Hospital | 1 | 2015 | 2 | 0.140 |
Why?
|
| Analysis of Variance | 5 | 2012 | 6366 | 0.130 |
Why?
|
| Specialties, Dental | 1 | 2015 | 35 | 0.130 |
Why?
|
| Orbit | 7 | 2007 | 426 | 0.130 |
Why?
|
| Eyelids | 2 | 1996 | 265 | 0.130 |
Why?
|
| Cell Nucleus | 7 | 2012 | 2969 | 0.130 |
Why?
|
| History, Ancient | 2 | 2016 | 212 | 0.130 |
Why?
|
| Craniofacial Dysostosis | 5 | 1989 | 73 | 0.130 |
Why?
|
| Blepharophimosis | 1 | 2015 | 22 | 0.130 |
Why?
|
| Jaw Abnormalities | 5 | 2001 | 27 | 0.130 |
Why?
|
| Monosomy | 1 | 2015 | 54 | 0.130 |
Why?
|
| PAX7 Transcription Factor | 2 | 2014 | 53 | 0.130 |
Why?
|
| Predictive Value of Tests | 6 | 2017 | 15078 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2014 | 8949 | 0.130 |
Why?
|
| Dental Research | 1 | 2015 | 58 | 0.130 |
Why?
|
| Endoscopy, Digestive System | 2 | 2008 | 345 | 0.130 |
Why?
|
| Linear Models | 7 | 2016 | 5953 | 0.130 |
Why?
|
| In Situ Hybridization | 1 | 2019 | 1950 | 0.130 |
Why?
|
| Aged | 26 | 2022 | 163288 | 0.130 |
Why?
|
| Orbital Fractures | 1 | 1996 | 110 | 0.130 |
Why?
|
| Occlusal Adjustment | 1 | 2014 | 8 | 0.130 |
Why?
|
| Tissue Scaffolds | 3 | 2011 | 956 | 0.130 |
Why?
|
| Bone Screws | 3 | 2011 | 520 | 0.130 |
Why?
|
| Dissection | 3 | 2011 | 295 | 0.120 |
Why?
|
| Vertical Dimension | 2 | 2008 | 35 | 0.120 |
Why?
|
| Reoperation | 4 | 2018 | 4201 | 0.120 |
Why?
|
| Tooth Diseases | 2 | 2012 | 77 | 0.120 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 553 | 0.120 |
Why?
|
| MyoD Protein | 2 | 2014 | 151 | 0.120 |
Why?
|
| Pediatrics | 3 | 2017 | 3475 | 0.120 |
Why?
|
| Surgical Wound Infection | 5 | 2011 | 1540 | 0.120 |
Why?
|
| Bibliometrics | 1 | 2018 | 339 | 0.120 |
Why?
|
| Career Choice | 2 | 2015 | 744 | 0.120 |
Why?
|
| Cafe-au-Lait Spots | 1 | 2013 | 18 | 0.120 |
Why?
|
| Sialadenitis | 2 | 2008 | 43 | 0.120 |
Why?
|
| Focal Infection, Dental | 3 | 1989 | 24 | 0.120 |
Why?
|
| Retropharyngeal Abscess | 1 | 2013 | 21 | 0.120 |
Why?
|
| Disease Progression | 5 | 2018 | 13286 | 0.120 |
Why?
|
| Physical Therapy Modalities | 4 | 2009 | 550 | 0.120 |
Why?
|
| Skull Base Neoplasms | 1 | 1997 | 284 | 0.110 |
Why?
|
| Students, Dental | 1 | 2015 | 160 | 0.110 |
Why?
|
| Molar, Third | 3 | 2007 | 49 | 0.110 |
Why?
|
| Bone Lengthening | 1 | 1993 | 19 | 0.110 |
Why?
|
| Equipment Design | 5 | 2011 | 3582 | 0.110 |
Why?
|
| Haversian System | 2 | 2010 | 9 | 0.110 |
Why?
|
| Personnel Selection | 1 | 2015 | 190 | 0.110 |
Why?
|
| Staff Development | 1 | 2015 | 223 | 0.110 |
Why?
|
| Combined Modality Therapy | 3 | 2016 | 8642 | 0.110 |
Why?
|
| Therapy, Computer-Assisted | 2 | 2006 | 271 | 0.110 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2013 | 44 | 0.110 |
Why?
|
| Chi-Square Distribution | 6 | 2003 | 3508 | 0.110 |
Why?
|
| Polyvinyls | 1 | 2014 | 157 | 0.110 |
Why?
|
| Seat Belts | 2 | 1993 | 57 | 0.110 |
Why?
|
| Career Mobility | 1 | 2015 | 262 | 0.110 |
Why?
|
| Spain | 1 | 2014 | 465 | 0.110 |
Why?
|
| Varicose Veins | 1 | 1994 | 154 | 0.110 |
Why?
|
| External Fixators | 1 | 1993 | 94 | 0.110 |
Why?
|
| HIV Seropositivity | 2 | 1995 | 971 | 0.110 |
Why?
|
| Mesoderm | 3 | 2012 | 686 | 0.110 |
Why?
|
| Alkaline Phosphatase | 5 | 2009 | 867 | 0.110 |
Why?
|
| Optic Nerve | 1 | 2016 | 554 | 0.110 |
Why?
|
| Interferons | 1 | 2016 | 706 | 0.110 |
Why?
|
| Length of Stay | 4 | 2014 | 6311 | 0.110 |
Why?
|
| Risk Factors | 16 | 2022 | 72296 | 0.100 |
Why?
|
| Ear | 1 | 2013 | 173 | 0.100 |
Why?
|
| Neurofibromin 1 | 1 | 2013 | 196 | 0.100 |
Why?
|
| Trismus | 3 | 2011 | 33 | 0.100 |
Why?
|
| Gingival Neoplasms | 1 | 2011 | 22 | 0.100 |
Why?
|
| Bone Substitutes | 2 | 2011 | 229 | 0.100 |
Why?
|
| Sound | 2 | 2013 | 260 | 0.100 |
Why?
|
| Models, Anatomic | 2 | 2014 | 691 | 0.100 |
Why?
|
| Immobilization | 3 | 2000 | 236 | 0.100 |
Why?
|
| Program Evaluation | 2 | 2015 | 2488 | 0.100 |
Why?
|
| Financing, Government | 1 | 2015 | 468 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2013 | 199 | 0.100 |
Why?
|
| Bacterial Infections | 2 | 1991 | 1401 | 0.100 |
Why?
|
| HLA Antigens | 1 | 2017 | 1382 | 0.100 |
Why?
|
| Facial Neoplasms | 2 | 1986 | 121 | 0.100 |
Why?
|
| Myofibroma | 1 | 2011 | 50 | 0.100 |
Why?
|
| Stents | 2 | 2007 | 3282 | 0.100 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1038 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 3 | 2012 | 1799 | 0.100 |
Why?
|
| Chondrogenesis | 1 | 2013 | 247 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 350 | 0.100 |
Why?
|
| Ear Diseases | 1 | 2013 | 170 | 0.100 |
Why?
|
| Case-Control Studies | 8 | 2016 | 21748 | 0.100 |
Why?
|
| Postoperative Complications | 12 | 2020 | 15297 | 0.100 |
Why?
|
| Respiratory Center | 1 | 2010 | 18 | 0.100 |
Why?
|
| Disease Models, Animal | 8 | 2000 | 18034 | 0.100 |
Why?
|
| Forecasting | 3 | 2013 | 2951 | 0.100 |
Why?
|
| Primary Nursing | 1 | 1990 | 11 | 0.100 |
Why?
|
| Myoblasts, Skeletal | 1 | 2011 | 76 | 0.100 |
Why?
|
| Prosthesis Failure | 2 | 2012 | 1206 | 0.090 |
Why?
|
| Calcium Phosphates | 1 | 2011 | 171 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 2 | 2013 | 2007 | 0.090 |
Why?
|
| Radionuclide Imaging | 6 | 2011 | 2031 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2013 | 2016 | 0.090 |
Why?
|
| Cadaver | 2 | 2011 | 1337 | 0.090 |
Why?
|
| Trigeminal Nerve | 2 | 2005 | 249 | 0.090 |
Why?
|
| Stem Cells | 4 | 2012 | 3567 | 0.090 |
Why?
|
| Keratins | 2 | 2003 | 515 | 0.090 |
Why?
|
| Publications | 1 | 2013 | 195 | 0.090 |
Why?
|
| Palate | 1 | 2010 | 123 | 0.090 |
Why?
|
| Ultrasonography | 5 | 2007 | 5984 | 0.090 |
Why?
|
| Masticatory Muscles | 1 | 1990 | 29 | 0.090 |
Why?
|
| Acrocephalosyndactylia | 2 | 1989 | 89 | 0.090 |
Why?
|
| Military Personnel | 1 | 2019 | 1133 | 0.090 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2011 | 124 | 0.090 |
Why?
|
| Polyesters | 1 | 2011 | 363 | 0.090 |
Why?
|
| Cell Proliferation | 5 | 2012 | 10483 | 0.090 |
Why?
|
| Cell Size | 1 | 2012 | 643 | 0.090 |
Why?
|
| Dentists | 2 | 2011 | 169 | 0.090 |
Why?
|
| Mouth Neoplasms | 2 | 2002 | 601 | 0.090 |
Why?
|
| Paranasal Sinuses | 1 | 2012 | 250 | 0.090 |
Why?
|
| Dilatation | 2 | 2008 | 291 | 0.090 |
Why?
|
| Osseointegration | 4 | 2006 | 276 | 0.090 |
Why?
|
| Evaluation Studies as Topic | 7 | 1998 | 1681 | 0.090 |
Why?
|
| Airway Resistance | 1 | 2010 | 404 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2021 | 2917 | 0.090 |
Why?
|
| Legislation as Topic | 2 | 1988 | 80 | 0.090 |
Why?
|
| Acromegaly | 1 | 2012 | 347 | 0.090 |
Why?
|
| Hypertrophy | 1 | 2011 | 569 | 0.090 |
Why?
|
| Snoring | 1 | 2010 | 191 | 0.090 |
Why?
|
| Hemangioma | 3 | 1986 | 738 | 0.080 |
Why?
|
| Radiosurgery | 1 | 1999 | 1329 | 0.080 |
Why?
|
| Fibroblasts | 3 | 2010 | 4162 | 0.080 |
Why?
|
| Radiography, Interventional | 1 | 2016 | 1095 | 0.080 |
Why?
|
| Facial Transplantation | 1 | 2012 | 226 | 0.080 |
Why?
|
| Rabbits | 6 | 1993 | 4894 | 0.080 |
Why?
|
| Chondrocytes | 2 | 2013 | 804 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2009 | 1107 | 0.080 |
Why?
|
| Fluorescent Dyes | 2 | 2010 | 1917 | 0.080 |
Why?
|
| Osteoarthritis | 4 | 2004 | 1036 | 0.080 |
Why?
|
| Lip | 2 | 1991 | 195 | 0.080 |
Why?
|
| Age of Onset | 1 | 2016 | 3270 | 0.080 |
Why?
|
| Mathematical Concepts | 1 | 2008 | 63 | 0.080 |
Why?
|
| Paresthesia | 2 | 2007 | 161 | 0.080 |
Why?
|
| Device Removal | 1 | 2014 | 656 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2010 | 6459 | 0.080 |
Why?
|
| Observer Variation | 2 | 2010 | 2593 | 0.080 |
Why?
|
| Faculty, Medical | 1 | 2017 | 1181 | 0.080 |
Why?
|
| Patients | 1 | 2015 | 900 | 0.080 |
Why?
|
| Dental Implantation, Endosseous | 3 | 1999 | 502 | 0.080 |
Why?
|
| United States | 6 | 2022 | 69872 | 0.080 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2011 | 235 | 0.080 |
Why?
|
| Neurofibromatosis 1 | 1 | 2013 | 570 | 0.080 |
Why?
|
| Minerals | 3 | 1990 | 275 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1486 | 0.080 |
Why?
|
| Rats | 12 | 2007 | 24252 | 0.080 |
Why?
|
| Biocompatible Materials | 6 | 2011 | 1736 | 0.080 |
Why?
|
| Molar | 3 | 2005 | 152 | 0.080 |
Why?
|
| Ibuprofen | 1 | 2009 | 236 | 0.080 |
Why?
|
| Microsurgery | 4 | 2012 | 796 | 0.080 |
Why?
|
| Feedback, Physiological | 1 | 2010 | 479 | 0.080 |
Why?
|
| Audiometry, Evoked Response | 1 | 2007 | 44 | 0.080 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 57776 | 0.080 |
Why?
|
| Bone Development | 1 | 1991 | 483 | 0.080 |
Why?
|
| Acid Phosphatase | 1 | 2007 | 143 | 0.080 |
Why?
|
| Proportional Hazards Models | 3 | 2016 | 12356 | 0.080 |
Why?
|
| Cryopreservation | 1 | 1992 | 670 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6539 | 0.080 |
Why?
|
| Parotid Diseases | 1 | 2007 | 46 | 0.080 |
Why?
|
| Osteoradionecrosis | 1 | 2007 | 49 | 0.080 |
Why?
|
| Skull | 7 | 2006 | 814 | 0.080 |
Why?
|
| Preoperative Care | 2 | 2013 | 2251 | 0.070 |
Why?
|
| Macroglossia | 1 | 1986 | 11 | 0.070 |
Why?
|
| Accidents, Traffic | 2 | 1993 | 819 | 0.070 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2007 | 204 | 0.070 |
Why?
|
| Phylogeny | 1 | 2014 | 2804 | 0.070 |
Why?
|
| Computer Simulation | 4 | 2010 | 6194 | 0.070 |
Why?
|
| Cell Differentiation | 7 | 2013 | 11486 | 0.070 |
Why?
|
| Polysomnography | 2 | 2011 | 1776 | 0.070 |
Why?
|
| Decompression, Surgical | 3 | 2012 | 594 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2010 | 729 | 0.070 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 686 | 0.070 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1941 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2013 | 6621 | 0.070 |
Why?
|
| Sural Nerve | 1 | 1986 | 106 | 0.070 |
Why?
|
| Spinal Nerves | 1 | 1986 | 86 | 0.070 |
Why?
|
| Prognosis | 12 | 2018 | 29060 | 0.070 |
Why?
|
| Carbon Dioxide | 1 | 2010 | 1150 | 0.070 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2011 | 546 | 0.070 |
Why?
|
| Algorithms | 4 | 2019 | 13882 | 0.070 |
Why?
|
| Patient Satisfaction | 3 | 2018 | 3395 | 0.070 |
Why?
|
| Fibula | 1 | 2008 | 269 | 0.070 |
Why?
|
| Chondromatosis, Synovial | 1 | 2005 | 17 | 0.070 |
Why?
|
| Bone Remodeling | 2 | 2002 | 575 | 0.070 |
Why?
|
| Lasers, Solid-State | 1 | 2007 | 169 | 0.070 |
Why?
|
| Tissue Transplantation | 1 | 2006 | 130 | 0.070 |
Why?
|
| History, 21st Century | 2 | 2016 | 1534 | 0.070 |
Why?
|
| Osteonecrosis | 1 | 2007 | 227 | 0.070 |
Why?
|
| Disease Management | 1 | 2016 | 2460 | 0.060 |
Why?
|
| Calcitonin | 1 | 2006 | 336 | 0.060 |
Why?
|
| Injections, Intra-Articular | 2 | 2016 | 278 | 0.060 |
Why?
|
| Phenotype | 3 | 2021 | 16367 | 0.060 |
Why?
|
| Bone and Bones | 6 | 2008 | 2576 | 0.060 |
Why?
|
| Mandibular Injuries | 4 | 2008 | 19 | 0.060 |
Why?
|
| Burkitt Lymphoma | 1 | 2007 | 327 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2016 | 9145 | 0.060 |
Why?
|
| Reference Values | 2 | 2009 | 4982 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2007 | 8300 | 0.060 |
Why?
|
| Collagen | 3 | 2010 | 2688 | 0.060 |
Why?
|
| Alveolar Ridge Augmentation | 2 | 1984 | 193 | 0.060 |
Why?
|
| San Francisco | 2 | 1995 | 159 | 0.060 |
Why?
|
| Oral Surgical Procedures, Preprosthetic | 1 | 1984 | 28 | 0.060 |
Why?
|
| Palatal Obturators | 1 | 2004 | 8 | 0.060 |
Why?
|
| Facial Hemiatrophy | 1 | 2004 | 22 | 0.060 |
Why?
|
| Bone Wires | 2 | 1994 | 122 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 1992 | 1364 | 0.060 |
Why?
|
| Neoplasms, Second Primary | 1 | 2012 | 1062 | 0.060 |
Why?
|
| Electrosurgery | 1 | 2004 | 58 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2007 | 968 | 0.060 |
Why?
|
| Parotitis | 3 | 2008 | 29 | 0.060 |
Why?
|
| Suture Techniques | 3 | 2007 | 798 | 0.060 |
Why?
|
| Keratin-10 | 1 | 2003 | 8 | 0.060 |
Why?
|
| Body Mass Index | 3 | 2010 | 12721 | 0.060 |
Why?
|
| HIV Seronegativity | 2 | 1995 | 211 | 0.060 |
Why?
|
| Dental Enamel | 2 | 2008 | 64 | 0.060 |
Why?
|
| Biopsy | 1 | 2016 | 6755 | 0.060 |
Why?
|
| Transplantation, Autologous | 5 | 2004 | 2124 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 4479 | 0.060 |
Why?
|
| Hearing | 1 | 2007 | 482 | 0.060 |
Why?
|
| Pliability | 1 | 2003 | 63 | 0.060 |
Why?
|
| Therapeutic Irrigation | 2 | 2003 | 301 | 0.060 |
Why?
|
| Leiomyosarcoma | 1 | 1988 | 477 | 0.060 |
Why?
|
| Neuroma | 3 | 2012 | 103 | 0.060 |
Why?
|
| Endoscopes | 1 | 2004 | 175 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 1351 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2916 | 0.060 |
Why?
|
| Ilium | 3 | 2005 | 154 | 0.060 |
Why?
|
| Placebos | 1 | 2007 | 1676 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2011 | 3480 | 0.050 |
Why?
|
| Cell Culture Techniques | 5 | 2013 | 1678 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 3 | 2008 | 2638 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1184 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2007 | 1728 | 0.050 |
Why?
|
| Cells, Cultured | 8 | 2013 | 19233 | 0.050 |
Why?
|
| Longitudinal Studies | 5 | 2017 | 13991 | 0.050 |
Why?
|
| Sheep | 3 | 1998 | 1437 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2013 | 2921 | 0.050 |
Why?
|
| Elastic Tissue | 1 | 2002 | 65 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3531 | 0.050 |
Why?
|
| Leiomyoma | 1 | 1988 | 730 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2021 | 23336 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 25039 | 0.050 |
Why?
|
| Collagen Type II | 2 | 2013 | 151 | 0.050 |
Why?
|
| Tunica Media | 1 | 2002 | 113 | 0.050 |
Why?
|
| Interviews as Topic | 2 | 2019 | 2539 | 0.050 |
Why?
|
| Rats, Inbred Strains | 3 | 1991 | 2186 | 0.050 |
Why?
|
| Treatment Failure | 2 | 1998 | 2618 | 0.050 |
Why?
|
| Neurologic Examination | 2 | 2012 | 931 | 0.050 |
Why?
|
| Touch | 3 | 2012 | 306 | 0.050 |
Why?
|
| Hyperplasia | 2 | 1995 | 1185 | 0.050 |
Why?
|
| Pilot Projects | 4 | 2009 | 8319 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2005 | 401 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 3841 | 0.050 |
Why?
|
| Severity of Illness Index | 4 | 2012 | 15535 | 0.050 |
Why?
|
| Dental Fistula | 1 | 1980 | 13 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 1984 | 1144 | 0.050 |
Why?
|
| Dental Implants | 2 | 2004 | 750 | 0.050 |
Why?
|
| Automation | 2 | 2015 | 584 | 0.050 |
Why?
|
| Single-Blind Method | 2 | 2007 | 1590 | 0.050 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2011 | 215 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 1997 | 7282 | 0.050 |
Why?
|
| Sella Turcica | 2 | 2014 | 119 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8432 | 0.050 |
Why?
|
| Fees, Medical | 1 | 2000 | 117 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9445 | 0.050 |
Why?
|
| Stroke | 1 | 2022 | 9981 | 0.040 |
Why?
|
| Tunica Intima | 1 | 2002 | 464 | 0.040 |
Why?
|
| Tooth Eruption | 2 | 1976 | 30 | 0.040 |
Why?
|
| Thermosensing | 2 | 2012 | 56 | 0.040 |
Why?
|
| Disease | 2 | 2011 | 680 | 0.040 |
Why?
|
| Hematoma | 2 | 2015 | 758 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 2009 | 25628 | 0.040 |
Why?
|
| Neoplasm, Residual | 2 | 2011 | 973 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 2282 | 0.040 |
Why?
|
| Alveoloplasty | 2 | 1997 | 22 | 0.040 |
Why?
|
| Microstomia | 1 | 1999 | 11 | 0.040 |
Why?
|
| Anodontia | 1 | 1999 | 49 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13693 | 0.040 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1999 | 75 | 0.040 |
Why?
|
| Cranial Nerve Neoplasms | 2 | 2012 | 129 | 0.040 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 895 | 0.040 |
Why?
|
| Culture Media | 2 | 2013 | 909 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2002 | 607 | 0.040 |
Why?
|
| Cellulitis | 1 | 1980 | 206 | 0.040 |
Why?
|
| Splints | 2 | 1990 | 111 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2002 | 687 | 0.040 |
Why?
|
| Polyglycolic Acid | 3 | 2005 | 407 | 0.040 |
Why?
|
| World War II | 1 | 2019 | 59 | 0.040 |
Why?
|
| Hospital Charges | 1 | 2000 | 362 | 0.040 |
Why?
|
| Hospitalization | 2 | 2014 | 10259 | 0.040 |
Why?
|
| Education, Medical, Graduate | 2 | 2017 | 2291 | 0.040 |
Why?
|
| Ectodermal Dysplasia | 1 | 1999 | 106 | 0.040 |
Why?
|
| Salivary Gland Diseases | 1 | 1978 | 37 | 0.040 |
Why?
|
| Hemophilia A | 2 | 1979 | 351 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2003 | 1686 | 0.040 |
Why?
|
| Tooth Erosion | 1 | 1977 | 9 | 0.040 |
Why?
|
| Gastric Juice | 1 | 1977 | 63 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2002 | 542 | 0.040 |
Why?
|
| Health Status | 1 | 2011 | 4034 | 0.040 |
Why?
|
| Cicatrix | 3 | 1993 | 764 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2002 | 596 | 0.040 |
Why?
|
| Logistic Models | 4 | 2004 | 13409 | 0.040 |
Why?
|
| Femoral Artery | 1 | 2002 | 845 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 1998 | 382 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2011 | 6896 | 0.040 |
Why?
|
| Cell Count | 3 | 2011 | 1856 | 0.040 |
Why?
|
| Hypesthesia | 1 | 1998 | 109 | 0.040 |
Why?
|
| Fractures, Open | 1 | 1998 | 101 | 0.040 |
Why?
|
| Intubation | 1 | 1997 | 141 | 0.040 |
Why?
|
| Factor VIII | 2 | 1979 | 347 | 0.040 |
Why?
|
| Gingival Hypertrophy | 1 | 1976 | 5 | 0.040 |
Why?
|
| Polymers | 4 | 2006 | 1621 | 0.040 |
Why?
|
| Carotid Artery Injuries | 1 | 1998 | 96 | 0.040 |
Why?
|
| HIV Infections | 2 | 1994 | 16715 | 0.040 |
Why?
|
| Sensory Thresholds | 2 | 2012 | 391 | 0.040 |
Why?
|
| Neoplasm Seeding | 1 | 1997 | 87 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1580 | 0.040 |
Why?
|
| Bone Marrow Cells | 3 | 2011 | 2513 | 0.040 |
Why?
|
| Anesthesia, Local | 1 | 1979 | 275 | 0.040 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1997 | 109 | 0.040 |
Why?
|
| Schools, Medical | 1 | 2004 | 881 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1999 | 599 | 0.040 |
Why?
|
| Egypt | 1 | 2016 | 100 | 0.040 |
Why?
|
| Facial Pain | 2 | 1995 | 127 | 0.040 |
Why?
|
| Dentistry, Operative | 1 | 1997 | 38 | 0.040 |
Why?
|
| Smiling | 1 | 1997 | 72 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2004 | 1210 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2002 | 838 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7882 | 0.040 |
Why?
|
| Anesthesia | 1 | 2008 | 1561 | 0.040 |
Why?
|
| Proplast | 1 | 1995 | 5 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1995 | 84 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 878 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1995 | 2232 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 1312 | 0.030 |
Why?
|
| Methods | 5 | 1998 | 1129 | 0.030 |
Why?
|
| Stomatitis | 1 | 1998 | 269 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 1998 | 434 | 0.030 |
Why?
|
| Sleep | 1 | 2011 | 4622 | 0.030 |
Why?
|
| Aging | 2 | 2009 | 8664 | 0.030 |
Why?
|
| Transplantation, Homologous | 4 | 2011 | 4777 | 0.030 |
Why?
|
| Foreign-Body Reaction | 1 | 1995 | 157 | 0.030 |
Why?
|
| Technetium | 3 | 1984 | 334 | 0.030 |
Why?
|
| Disease Susceptibility | 2 | 2007 | 1782 | 0.030 |
Why?
|
| Pain Threshold | 2 | 2012 | 584 | 0.030 |
Why?
|
| Education, Dental | 1 | 1977 | 215 | 0.030 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1995 | 139 | 0.030 |
Why?
|
| Lactic Acid | 3 | 2005 | 1132 | 0.030 |
Why?
|
| Mental Disorders | 3 | 1990 | 6598 | 0.030 |
Why?
|
| Facies | 1 | 2015 | 197 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 1998 | 662 | 0.030 |
Why?
|
| Root Resorption | 2 | 2011 | 42 | 0.030 |
Why?
|
| AIDS-Related Complex | 1 | 1994 | 110 | 0.030 |
Why?
|
| Cell Division | 4 | 2003 | 4569 | 0.030 |
Why?
|
| Photography | 1 | 1997 | 520 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 1997 | 466 | 0.030 |
Why?
|
| Remission Induction | 2 | 2011 | 2385 | 0.030 |
Why?
|
| Dental Care for Disabled | 1 | 1993 | 20 | 0.030 |
Why?
|
| Powders | 3 | 1984 | 80 | 0.030 |
Why?
|
| Soft Tissue Infections | 1 | 1995 | 155 | 0.030 |
Why?
|
| Reference Standards | 2 | 1995 | 1025 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 1998 | 638 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2024 | 2305 | 0.030 |
Why?
|
| Jugular Veins | 1 | 1994 | 204 | 0.030 |
Why?
|
| Prostheses and Implants | 2 | 2011 | 1387 | 0.030 |
Why?
|
| Veins | 1 | 1978 | 770 | 0.030 |
Why?
|
| Sex Ratio | 1 | 2013 | 110 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 2960 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2015 | 460 | 0.030 |
Why?
|
| Phospholipase C beta | 1 | 2013 | 50 | 0.030 |
Why?
|
| Pericardial Effusion | 1 | 1975 | 247 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2017 | 9849 | 0.030 |
Why?
|
| Foot Deformities, Congenital | 1 | 1993 | 59 | 0.030 |
Why?
|
| Incidence | 3 | 2007 | 20952 | 0.030 |
Why?
|
| Chromogranins | 1 | 2013 | 160 | 0.030 |
Why?
|
| Ossification, Heterotopic | 1 | 1995 | 239 | 0.030 |
Why?
|
| Homosexuality | 1 | 1993 | 262 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2013 | 89 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1184 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1978 | 1066 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 1997 | 1677 | 0.030 |
Why?
|
| Steroids | 2 | 2008 | 930 | 0.030 |
Why?
|
| Fractures, Ununited | 1 | 1994 | 165 | 0.030 |
Why?
|
| Tooth Mobility | 1 | 2011 | 21 | 0.030 |
Why?
|
| Rest | 1 | 1997 | 901 | 0.030 |
Why?
|
| Somatosensory Disorders | 1 | 2012 | 47 | 0.030 |
Why?
|
| Europe | 1 | 2019 | 3338 | 0.030 |
Why?
|
| Exudates and Transudates | 1 | 1992 | 172 | 0.030 |
Why?
|
| Plastics | 1 | 1992 | 123 | 0.030 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2011 | 21 | 0.030 |
Why?
|
| Curettage | 1 | 2011 | 73 | 0.030 |
Why?
|
| Hand Deformities, Congenital | 1 | 1993 | 146 | 0.030 |
Why?
|
| Palatal Expansion Technique | 1 | 1992 | 25 | 0.030 |
Why?
|
| Suppuration | 1 | 2011 | 56 | 0.030 |
Why?
|
| Patient Care | 1 | 1997 | 640 | 0.030 |
Why?
|
| Osteocytes | 2 | 2004 | 197 | 0.030 |
Why?
|
| Facial Paralysis | 2 | 1994 | 338 | 0.030 |
Why?
|
| Movement | 4 | 2005 | 1471 | 0.030 |
Why?
|
| Noonan Syndrome | 1 | 2012 | 122 | 0.020 |
Why?
|
| Bisexuality | 1 | 1993 | 269 | 0.020 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1993 | 243 | 0.020 |
Why?
|
| Tissue Preservation | 2 | 1982 | 182 | 0.020 |
Why?
|
| Graphite | 1 | 2011 | 66 | 0.020 |
Why?
|
| Fractures, Comminuted | 1 | 2011 | 52 | 0.020 |
Why?
|
| Mutation | 2 | 2013 | 29786 | 0.020 |
Why?
|
| Bacteremia | 1 | 1998 | 963 | 0.020 |
Why?
|
| Carotid Artery Diseases | 1 | 1998 | 879 | 0.020 |
Why?
|
| Oxacillin | 2 | 1985 | 42 | 0.020 |
Why?
|
| Data Display | 1 | 2011 | 182 | 0.020 |
Why?
|
| Oral Ulcer | 1 | 2011 | 96 | 0.020 |
Why?
|
| Metals | 1 | 1995 | 719 | 0.020 |
Why?
|
| Cutaneous Fistula | 1 | 2011 | 78 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2002 | 2002 | 0.020 |
Why?
|
| Computers, Handheld | 1 | 2013 | 208 | 0.020 |
Why?
|
| Hydroxyapatites | 1 | 1990 | 75 | 0.020 |
Why?
|
| DNA | 3 | 2006 | 7294 | 0.020 |
Why?
|
| Fiducial Markers | 1 | 2011 | 136 | 0.020 |
Why?
|
| Periodontal Diseases | 3 | 1984 | 449 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1977 | 1487 | 0.020 |
Why?
|
| Dental Care | 1 | 1993 | 262 | 0.020 |
Why?
|
| Equipment Failure | 1 | 1992 | 578 | 0.020 |
Why?
|
| Ceramics | 1 | 1990 | 105 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2013 | 592 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 1998 | 2765 | 0.020 |
Why?
|
| Computer Systems | 1 | 2011 | 483 | 0.020 |
Why?
|
| Patient Care Team | 2 | 2020 | 2531 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2013 | 837 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2011 | 298 | 0.020 |
Why?
|
| Titanium | 1 | 1992 | 494 | 0.020 |
Why?
|
| Surface Properties | 1 | 1992 | 1184 | 0.020 |
Why?
|
| Medical History Taking | 1 | 1993 | 784 | 0.020 |
Why?
|
| Amelogenin | 1 | 2009 | 15 | 0.020 |
Why?
|
| Nursing Staff | 1 | 1990 | 129 | 0.020 |
Why?
|
| Immune System Diseases | 1 | 2011 | 261 | 0.020 |
Why?
|
| Hypertelorism | 2 | 1986 | 32 | 0.020 |
Why?
|
| Neck | 2 | 1989 | 698 | 0.020 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1993 | 525 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 1995 | 2377 | 0.020 |
Why?
|
| Facial Injuries | 3 | 1987 | 183 | 0.020 |
Why?
|
| Pain, Postoperative | 2 | 2011 | 1643 | 0.020 |
Why?
|
| Obesity | 1 | 2011 | 12746 | 0.020 |
Why?
|
| Scalp | 1 | 1991 | 380 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 1992 | 491 | 0.020 |
Why?
|
| Salivary Gland Calculi | 1 | 2008 | 16 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2012 | 600 | 0.020 |
Why?
|
| Incisor | 2 | 1997 | 179 | 0.020 |
Why?
|
| Uterus | 1 | 1992 | 711 | 0.020 |
Why?
|
| Heterozygote | 1 | 2015 | 2804 | 0.020 |
Why?
|
| Orthodontic Appliances, Removable | 1 | 1988 | 29 | 0.020 |
Why?
|
| Paranasal Sinus Diseases | 1 | 1989 | 116 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2013 | 764 | 0.020 |
Why?
|
| Dry Socket | 1 | 2007 | 7 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 5388 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 2007 | 1420 | 0.020 |
Why?
|
| Quality of Life | 3 | 2022 | 12802 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2005 | 9274 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1988 | 554 | 0.020 |
Why?
|
| Abscess | 1 | 2011 | 607 | 0.020 |
Why?
|
| Decalcification Technique | 2 | 1990 | 6 | 0.020 |
Why?
|
| Lymphoma | 1 | 1976 | 1877 | 0.020 |
Why?
|
| Prevalence | 2 | 1995 | 15221 | 0.020 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1993 | 623 | 0.020 |
Why?
|
| Horner Syndrome | 1 | 2007 | 37 | 0.020 |
Why?
|
| Toothache | 1 | 2007 | 34 | 0.020 |
Why?
|
| Cell Separation | 1 | 2013 | 1751 | 0.020 |
Why?
|
| Edema | 1 | 2011 | 789 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 1431 | 0.020 |
Why?
|
| Mucopolysaccharidoses | 1 | 1986 | 27 | 0.020 |
Why?
|
| Orbital Diseases | 1 | 1989 | 181 | 0.020 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 1986 | 43 | 0.020 |
Why?
|
| Dental Prosthesis, Implant-Supported | 2 | 1999 | 215 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1993 | 1301 | 0.020 |
Why?
|
| Lymphangioma | 1 | 1986 | 65 | 0.020 |
Why?
|
| Syndrome | 1 | 1993 | 3252 | 0.020 |
Why?
|
| Water | 1 | 2013 | 1395 | 0.020 |
Why?
|
| Video Recording | 1 | 2011 | 949 | 0.020 |
Why?
|
| Mitosis | 1 | 2011 | 1208 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 1990 | 534 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3921 | 0.020 |
Why?
|
| Lip Neoplasms | 1 | 1986 | 37 | 0.020 |
Why?
|
| Penicillin G | 1 | 1985 | 42 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 1995 | 1848 | 0.020 |
Why?
|
| Pain | 4 | 2007 | 4988 | 0.020 |
Why?
|
| Psychophysiologic Disorders | 1 | 1987 | 228 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2013 | 1788 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 1997 | 3611 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2011 | 1771 | 0.020 |
Why?
|
| Nerve Transfer | 1 | 2007 | 120 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2005 | 90 | 0.020 |
Why?
|
| Transplantation, Heterotopic | 1 | 2005 | 175 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2005 | 198 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2004 | 12244 | 0.020 |
Why?
|
| Vincristine | 1 | 2007 | 1039 | 0.020 |
Why?
|
| Prolactin | 1 | 2007 | 669 | 0.020 |
Why?
|
| Tongue Neoplasms | 1 | 1986 | 180 | 0.020 |
Why?
|
| Violence | 1 | 2011 | 909 | 0.020 |
Why?
|
| Nerve Compression Syndromes | 1 | 1986 | 160 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 4642 | 0.020 |
Why?
|
| Bone Diseases, Developmental | 1 | 1986 | 130 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2005 | 273 | 0.020 |
Why?
|
| Neurofibroma | 1 | 1985 | 106 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17446 | 0.020 |
Why?
|
| Omentum | 1 | 2005 | 170 | 0.020 |
Why?
|
| Mouth | 2 | 1978 | 374 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 318 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2008 | 1107 | 0.020 |
Why?
|
| California | 1 | 1988 | 1402 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2005 | 719 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2013 | 1099 | 0.020 |
Why?
|
| Bioreactors | 1 | 2005 | 236 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 2504 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2121 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4185 | 0.010 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2006 | 319 | 0.010 |
Why?
|
| Arthroscopy | 1 | 1990 | 926 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 12073 | 0.010 |
Why?
|
| Curriculum | 1 | 2017 | 3605 | 0.010 |
Why?
|
| Tooth Fractures | 2 | 1980 | 28 | 0.010 |
Why?
|
| Fever | 1 | 2011 | 1616 | 0.010 |
Why?
|
| Mathematics | 1 | 2005 | 728 | 0.010 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 1985 | 171 | 0.010 |
Why?
|
| Silver Staining | 1 | 2003 | 64 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 987 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6171 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 653 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1364 | 0.010 |
Why?
|
| Occipital Bone | 1 | 2002 | 54 | 0.010 |
Why?
|
| Parietal Bone | 1 | 2002 | 47 | 0.010 |
Why?
|
| Arteriovenous Fistula | 1 | 1986 | 315 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 1990 | 1095 | 0.010 |
Why?
|
| Adjustment Disorders | 1 | 1982 | 70 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 2003 | 169 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 1986 | 555 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 2 | 2007 | 2736 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2002 | 288 | 0.010 |
Why?
|
| Hypotension | 1 | 2008 | 884 | 0.010 |
Why?
|
| Research Design | 1 | 1997 | 5984 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 1987 | 865 | 0.010 |
Why?
|
| Osteochondritis | 1 | 1981 | 23 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1981 | 98 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
| Tomography, X-Ray | 1 | 1981 | 61 | 0.010 |
Why?
|
| Age Determination by Skeleton | 1 | 1982 | 129 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2007 | 2242 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 1981 | 257 | 0.010 |
Why?
|
| Head Protective Devices | 1 | 2002 | 114 | 0.010 |
Why?
|
| Pregnancy | 3 | 1992 | 29144 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1994 | 3966 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2007 | 2879 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1997 | 9955 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2000 | 7658 | 0.010 |
Why?
|
| Root Canal Therapy | 1 | 1980 | 65 | 0.010 |
Why?
|
| Methotrexate | 1 | 2007 | 1728 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3476 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 12952 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4851 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1988 | 6313 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1986 | 1125 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10637 | 0.010 |
Why?
|
| Estrogens | 1 | 2007 | 1566 | 0.010 |
Why?
|
| Regeneration | 1 | 2009 | 1485 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1985 | 2726 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 2727 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2009 | 2441 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1985 | 501 | 0.010 |
Why?
|
| Otitis Media | 1 | 1982 | 277 | 0.010 |
Why?
|
| Graft Survival | 2 | 2008 | 3737 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5218 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2012 | 3444 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2005 | 3689 | 0.010 |
Why?
|
| Jaw, Edentulous | 1 | 1999 | 93 | 0.010 |
Why?
|
| Thrombosis | 1 | 1992 | 2968 | 0.010 |
Why?
|
| Down Syndrome | 1 | 1986 | 880 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 5023 | 0.010 |
Why?
|
| Speech | 1 | 2003 | 541 | 0.010 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1998 | 53 | 0.010 |
Why?
|
| Submandibular Gland | 1 | 1978 | 86 | 0.010 |
Why?
|
| Oral Fistula | 1 | 1997 | 13 | 0.010 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1998 | 148 | 0.010 |
Why?
|
| Respiratory Tract Fistula | 1 | 1997 | 26 | 0.010 |
Why?
|
| Jaw, Edentulous, Partially | 1 | 1997 | 85 | 0.010 |
Why?
|
| Anthropometry | 1 | 2002 | 1350 | 0.010 |
Why?
|
| Anticoagulants | 2 | 2007 | 4600 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 2383 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10943 | 0.010 |
Why?
|
| Nose Diseases | 1 | 1997 | 79 | 0.010 |
Why?
|
| Self Concept | 1 | 2003 | 1025 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1979 | 690 | 0.010 |
Why?
|
| Smoking | 1 | 1994 | 8987 | 0.010 |
Why?
|
| Personality Disorders | 1 | 1981 | 713 | 0.010 |
Why?
|
| Skin | 1 | 1990 | 4372 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2011 | 3086 | 0.010 |
Why?
|
| Dental Caries | 1 | 1980 | 415 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3690 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 4925 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1991 | 5101 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1981 | 707 | 0.010 |
Why?
|
| Calcinosis | 1 | 2005 | 1499 | 0.010 |
Why?
|
| Tooth, Impacted | 1 | 1976 | 42 | 0.010 |
Why?
|
| Dental Implants, Single-Tooth | 1 | 1997 | 117 | 0.010 |
Why?
|
| Survival Rate | 1 | 1990 | 12788 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 2373 | 0.010 |
Why?
|
| Tooth Root | 1 | 1976 | 165 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1994 | 5749 | 0.010 |
Why?
|
| Acute Disease | 2 | 1978 | 7147 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 4257 | 0.010 |
Why?
|
| Body Image | 1 | 1979 | 610 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4751 | 0.010 |
Why?
|
| Vomiting | 1 | 1977 | 637 | 0.010 |
Why?
|
| Uremia | 1 | 1975 | 200 | 0.010 |
Why?
|
| Cardiac Tamponade | 1 | 1975 | 173 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2003 | 2052 | 0.010 |
Why?
|
| Cloxacillin | 1 | 1973 | 6 | 0.010 |
Why?
|
| Bacitracin | 1 | 1973 | 25 | 0.010 |
Why?
|
| Oxygen | 1 | 2005 | 4189 | 0.010 |
Why?
|
| Sarcoma | 1 | 1985 | 1897 | 0.010 |
Why?
|
| Carcinoma | 1 | 1985 | 2375 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2007 | 6254 | 0.010 |
Why?
|
| Nerve Block | 1 | 1979 | 644 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 1978 | 752 | 0.010 |
Why?
|
| Fascia | 1 | 1993 | 135 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3255 | 0.010 |
Why?
|
| Psychotherapy | 1 | 1981 | 1642 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 2002 | 1289 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1993 | 876 | 0.010 |
Why?
|
| Cytophotometry | 1 | 1991 | 7 | 0.010 |
Why?
|
| Thromboembolism | 1 | 1998 | 987 | 0.010 |
Why?
|
| Penicillins | 1 | 1973 | 380 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2005 | 4245 | 0.010 |
Why?
|
| Durapatite | 1 | 1990 | 161 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2007 | 5181 | 0.010 |
Why?
|
| Diploidy | 1 | 1989 | 138 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 7798 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 9584 | 0.010 |
Why?
|
| Necrosis | 1 | 1973 | 1643 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 1981 | 3747 | 0.010 |
Why?
|
| Occupational Dentistry | 1 | 1967 | 1 | 0.000 |
Why?
|
| Quality Control | 1 | 1990 | 841 | 0.000 |
Why?
|
| Tooth Injuries | 1 | 1967 | 15 | 0.000 |
Why?
|
| Hypertension | 1 | 2007 | 8479 | 0.000 |
Why?
|
| Workers' Compensation | 1 | 1967 | 152 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2002 | 13035 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11525 | 0.000 |
Why?
|
| Traumatology | 1 | 1987 | 88 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1990 | 1101 | 0.000 |
Why?
|
| Penicillin Resistance | 1 | 1985 | 84 | 0.000 |
Why?
|
| Clindamycin | 1 | 1985 | 139 | 0.000 |
Why?
|
| Skin Neoplasms | 1 | 1984 | 5692 | 0.000 |
Why?
|
| Ear Canal | 1 | 1985 | 146 | 0.000 |
Why?
|
| Radiation Dosage | 1 | 1993 | 1928 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 11126 | 0.000 |
Why?
|
| Prenatal Diagnosis | 1 | 1990 | 1236 | 0.000 |
Why?
|
| Rhinoplasty | 1 | 1986 | 226 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1986 | 1536 | 0.000 |
Why?
|
| Arm | 1 | 1984 | 589 | 0.000 |
Why?
|
| Thorax | 1 | 1984 | 547 | 0.000 |
Why?
|
| Ophthalmology | 1 | 1987 | 508 | 0.000 |
Why?
|
| Interprofessional Relations | 1 | 1987 | 1011 | 0.000 |
Why?
|
| Otolaryngology | 1 | 1987 | 645 | 0.000 |
Why?
|
| Disability Evaluation | 1 | 1967 | 1828 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 20824 | 0.000 |
Why?
|
| Dogs | 1 | 1984 | 3912 | 0.000 |
Why?
|
| Leg | 1 | 1984 | 1116 | 0.000 |
Why?
|
| Gait | 1 | 1984 | 793 | 0.000 |
Why?
|
| Drainage | 1 | 1984 | 1142 | 0.000 |
Why?
|
| Mice | 1 | 2005 | 81201 | 0.000 |
Why?
|
| Maxillary Fractures | 1 | 1977 | 20 | 0.000 |
Why?
|
| Cell Line | 1 | 1990 | 16000 | 0.000 |
Why?
|
| Spinal Fusion | 1 | 1984 | 1241 | 0.000 |
Why?
|
| Blindness | 1 | 1979 | 615 | 0.000 |
Why?
|
| Bacteria | 1 | 1985 | 2115 | 0.000 |
Why?
|
| Communication | 1 | 1987 | 3750 | 0.000 |
Why?
|
| Eyebrows | 1 | 1973 | 28 | 0.000 |
Why?
|
| Quality of Health Care | 1 | 1987 | 4369 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1979 | 1199 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1976 | 1680 | 0.000 |
Why?
|
| Jaw Fractures | 1 | 1967 | 4 | 0.000 |
Why?
|
| United States Public Health Service | 1 | 1967 | 31 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1978 | 3712 | 0.000 |
Why?
|
| Brain | 1 | 1979 | 26388 | 0.000 |
Why?
|